Abstract
G protein coupled receptors (GPCRs) are the main mediators of signal transduction in the central nervous system. Therefore, it is not surprising that many GPCRs have long been investigated for their role in the development of anxiety and mood disorders, as well as in the mechanism of action of antidepressant therapies. Importantly, the endogenous ligands for a large group of GPCRs have not yet been identified and are therefore known as orphan GPCRs (oGPCRs). Nonetheless, growing evidence from animal studies, together with genome wide association studies (GWAS) and post-mortem transcriptomic analysis in patients, pointed at many oGPCRs as potential pharmacological targets. Among these discoveries, we summarize in this review how emotional behaviors are modulated by the following oGPCRs: ADGRB2 (BAI2), ADGRG1 (GPR56), GPR3, GPR26, GPR37, GPR50, GPR52, GPR61, GPR62, GPR88, GPR135, GPR158, and GPRC5B.
Subject
Genetics(clinical),Genetics
Reference239 articles.
1. A clinical and pharmacodynamic evaluation of iproniazid as a psychic energizer;Loomer;Psychiatr. Res. Rep. Am. Psychiatr. Assoc.,1957
2. [Treatment of depressive states with an iminodibenzyl derivative (G 22355)];Kuhn;Schweiz Med. Wochenschr.,1957
3. Depressive states during Rauwolfia therapy for arterial hypertension; a report of 30 cases;Lemieux;Can. Med. Assoc. J.,1956
4. Dopamine System Dysregulation in Major Depressive Disorders
5. HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献